Citadel Advisors »

Ascendis Pharma A/s shares owned by Citadel Advisors

Quarter-by-quarter ownership of Ascendis Pharma A/s shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Ascendis Pharma A/s

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A/s held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A/s by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.8M 2.7M 1.03

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Ascendis Pharma A/s

Wolverine Asset Management
Braidwell
Franklin Resources
Aviva
Readystate Asset Management
D. E. Shaw & Co
Point72 Asset Management
Zazove Associates
CSS
Jane Street
Calamos Advisors
Capstone Investment Advisors
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
SSI Investment Management
DAFNA Capital Management

View all funds holding Ascendis Pharma A/s